Comment on: Induction treatment of ANCA-associated vasculitis with a single dose of rituximab

被引:1
|
作者
Moog, Philipp [1 ]
Schulze-Koops, Hendrik [1 ]
Thuermel, Klaus [2 ]
机构
[1] Univ Munich, Rheumaeinheit, Med Klin & Poliklin 4, D-80336 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, D-80290 Munich, Germany
关键词
D O I
10.1093/rheumatology/keu353
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:372 / 373
页数:3
相关论文
共 50 条
  • [31] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (04): : 168 - 168
  • [32] Recommendations on the use of rituximab for ANCA-associated vasculitis
    Gause, A. M.
    Rubbert-Roth, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (03): : 287 - 289
  • [33] Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
    Springer, Jason
    Funk, Ryan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] Rituximab or Azathioprine Maintenance in ANCA-Associated Vasculitis
    Vandergheynst, Frederic
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04): : 385 - 386
  • [35] Extending the Indications for Rituximab in ANCA-Associated Vasculitis
    Jayne, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19): : 1839 - 1840
  • [36] Comparison Between Induction with Rituximab and Cyclophosphamide in Treatment of Childhood-Onset ANCA-Associated Vasculitis
    Gagne, Samuel
    Morishita, Kimberly
    Bosman, Else
    Sivaraman, Vidya
    Cabral, David
    Klamer, Brett
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 170 - 172
  • [37] Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohort
    Chasseur, P.
    Blockmans, D.
    von Frenckell, C.
    Nicolas, J-B.
    Regniers, C.
    Vandergheynst, F.
    ACTA CLINICA BELGICA, 2020, 75 (03) : 163 - 169
  • [38] Rituximab for ANCA-associated vasculitis: The UK experience
    Jayne, David
    PRESSE MEDICALE, 2013, 42 (04): : 532 - 534
  • [39] Remission induction in ANCA-associated vasculitis
    Hellmich, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 194 - 195
  • [40] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    McAdoo, Stephen
    Galliford, Jack
    Griffith, Megan
    Levy, Jeremy
    Cairns, Tom
    Pusey, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33